![Axial Biotherapeutics Raises $25 Million in Series B Financing](https://www.seventure.fr/wp-content/uploads/2019/02/4__104270789-322x211.jpg)
11 March 2019
Axial Biotherapeutics Raises $25 Million in Series B Financing
Funds will be used to advance Axial’s gut-targeted programs in Parkinson’s Disease and Autism Spectrum Disorder. Seventure Partners commits new funding from...
Search
Funds will be used to advance Axial’s gut-targeted programs in Parkinson’s Disease and Autism Spectrum Disorder. Seventure Partners commits new funding from...